I receive many emails from people asking me to help them get access to insulin. This column is for you, the person and family member who has reached out to me for help in gaining access to free or affordable insulin. Dear PWD: Unfortunately, not everyone has access to good health insurance. For some, having … Continue reading AskNadia: I Need Free or Inexpensive Insulin
Dear Nadia, Are there a generic insulin? If so, where can I buy it? Jessie Dear Jessie, There are currently no generic insulin in the U.S. market because the patents on the branded insulins have not expired. Every time a patented insulin is improved and approved by the FDA, the patent for that insulin is … Continue reading AskNadia: Buying Generic Insulin in the U.S.
Physicians Tout Lantus, Calling it an ‘Advancement in Basal Insulin Coverage’
Bridgewater, NJ – July 21, 2015 – Sanofi US announced today that the company has secured broad accessibility with private insurance companies and the U.S. government for Toujeo® (insulin glargine injection) 300 Units/mL since launch. The widespread access is a result of key contracts in both the public and private sectors. Toujeo®, a once-daily, long-acting … Continue reading Once-Daily Long-Acting Basal Insulin Toujeo
A young man in his early thirties struggles through traffic on his small Honda motorbike. As he enjoys a short break at a traffic signal, one foot on the road, his eyes are attracted to a billboard picturing a succulent burger. While he gazes, fantasizing about lunch, his vision starts to blur. The light turns … Continue reading The Diabetes Epidemic in India
An Interview With DiabetesSisters Founder Brandy Barnes
From the Spring Research Guide
As the Insulin Market Shrinks, How Good and How Safe Are the Remaining Options?
A Web-based product from Aventis Pharmaceuticals